Overall, modulating the expression of apoptotic members of the Bcl-2 protein family and preventing translocation of AIF, Cyt-c, and Smac from the mitochondria into the cytoplasmic matrix can serve as targets for the treatment of ischemic stroke. The gene discussed is BCL2; the disease is ischemic stroke.